AADC polynucleotides for the treatment of Parkinson's disease
US11759506B2 · kind B2 · utility
1Cited by
253References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 26, 2019 |
| Grant date | Sep 19, 2023 |
| Priority date | — |
| Expiry date | Dec 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y401/01028
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.